Your session is about to expire
← Back to Search
Photobiomodulation Therapy for Mouth Sores from Bone Marrow Transplant
Study Summary
This trial is evaluating the use of a device called the THOR LX2.3 with LED Lollipop for the prevention of oral mucositis in patients undergoing myeloablative allogeneic hematopoietic cell transplantation (alloHCT). This device uses light to help prevent mucositis, a common side effect of alloHCT.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am 18 years old or older.I have had radiation therapy to my head or neck.I have received PBMT in my mouth within the last month before my stem cell transplant.I am scheduled to receive palifermin for mouth sore prevention.I have a history of reacting badly to sunlight.I am scheduled for a specific bone marrow transplant with FluBu4 and Tac-Mtx.
- Group 1: INTRAORAL PBMT IN PATIENTS UNDERGOING alloHCT
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is enrollment ongoing for this trial?
"Affirmative. According to clinicaltrials.gov, the study is currently enrolling participants with its initial posting on June 10th 2022 and most recent update being June 27th 2022. They are looking for 20 patients from 1 medical site."
What is the size of the sample pool for this clinical endeavor?
"Indeed, the information hosted on clinicaltrials.gov reveals that this study is actively recruiting patients. Initially posted on June 10th 2022 and recently updated June 27th 2022, it is seeking 20 participants from one site in particular."
Share this study with friends
Copy Link
Messenger